-40.8%
BMNR vs GSK
+31.2%
-72.0%
-78.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.6% | -1.9% | -3.7% | -5.8% |
| 7D | +4.9% | -1.8% | +6.7% | +4.7% |
| 30D | +35.5% | -2.2% | +37.7% | +35.0% |
| 3M | +39.6% | -1.8% | +41.4% | +39.0% |
| 6M | +18.2% | -10.6% | +28.8% | +14.9% |
| YTD | -8.0% | +4.4% | -12.5% | -5.3% |
| 1Y | -40.8% | +30.4% | -71.2% | -32.9% |
| All | -40.8% | +31.2% | -72.0% | -32.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling